Challenged with developing the first medicine against HIV
Dr. Marty St. Clair is one of the people who has been integral to our continued involvement, passion and commitment to improving the health and lives of those living with HIV. Marty herself was working as a research scientist at Burroughs Wellcome (now GSK) in the early 1980s, and was part of the team who discovered and helped develop the very first HIV drug – azidothymidine (AZT, also known as zidovudine).
At a conference in 2016, Marty spoke about the discovery of AZT, providing not just a scientific overview of its development, but placing its development in sociohistorical context around the discovery of HIV and feeling/attitudes at the time. Read more about her presentation here.
Marty was part of a team of highly experienced scientists – all directly involved in the discovery and development of AZT. People who inspired not only each other, but also the next generation of HIV researchers, who continue the search for more better treatments.
Today, Marty joins her ViiV Healthcare colleagues headquartered in Research Triangle Park – all of whom are working to solve the mystery of HIV.
At ViiV Healthcare, we work together with stakeholders to support access to our HIV medicines for affected populations in the U.S. and across the globe. For residents, learn more about the programs and services we support across the US.
Learn more about ViiV Healthcare in the U.S., or follow us @ViiVUS.